Safety of Pfizer-BioNTech COVID-19 vaccine in children ages 5 to 17
JAMA Pediatrics
About The Study: Among 20 health outcomes that were monitored in near real time in this study including more than 3 million children ages 5 to 17 who received the Pfizer-BioNTech COVID-19 vaccine, a safety signal was identified for only myocarditis or pericarditis. Consistent with other published reports, these results provide additional evidence that COVID-19 vaccines are safe in children.
Authors: Steven A. Anderson, Ph.D., M.P.P., of the Food and Drug Administration in Silver Spring, Maryland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2023.1440)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.1440?guestAccessKey=729f6a2e-2023-46f0-a824-f3998e81ff05&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052223
END
Authors: Steven A. Anderson, Ph.D., M.P.P., of the Food and Drug Administration in Silver Spring, Maryland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2023.1440)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.1440?guestAccessKey=729f6a2e-2023-46f0-a824-f3998e81ff05&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052223
END